| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Unidade de Endocrinologia do Desenvolvimento e Laboratório de Hormônios e Genética Molecular da Disciplina de Endocrinologia (T.A.S.S.B., A.E.C.B., G.M., J.A.M.M., I.J.P.A., B.B.M.), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo 01060970, Brazil; Serviço de Endocrinologia Pediátrica (C.A.L.), Departamento de Pediatria da Santa Casa, São Paulo, Brazil; Departamento de Clínica Médica I (M.V.L.), Universidade Federal do Rio Grande do Norte, Natal, Brazil 59010-180
Address all correspondence and requests for reprints to: Berenice B. Mendonca, M.D., Hospital das Clínicas, FMUSP, Divisão de Endocrinologia, Caixa Postal 3671, São Paulo, 01060970, Brazil. E-mail: beremen{at}usp.br
The aim of our study was to determine, by allele-specific PCR, the
frequency of point mutations in 130 Brazilian patients with the
classical and nonclassical forms of 21-hydroxylase deficiency and to
correlate genotype with phenotype. The most frequent mutations were I2
splice (41.8% in salt wasting), I172N (32.6% in simple
virilizing), and V281L (40.2% in late onset form). The frequency of
the 9 most common point mutations was similar to that reported for
other countries, except for Del 8 nt and Cluster, which were less
frequent in the classical form. Rarer mutations such as P453S, G291S,
I7 splice, W405X, R483P, and R483
frameshift were rarely found or
were absent. The 93 fully genotyped patients were classified into 3
mutation groups, based on the degree of enzymatic activity (group A,
<2%; group B,
2%, and group C, >18%). In group A, 62% of the
cases presented the salt wasting form; in group B, 96% the simple
virilizing form; and in group C, 88% the late onset form. We diagnosed
80% of the affected alleles after screening for large rearrangements
and 15 point mutations. The absence of previously described mutations
in 20% of the affected alleles suggests the presence of new mutations
in our population.
This article has been cited by other articles:
![]() |
L. G. Gomes, N. Huang, V. Agrawal, B. B. Mendonca, T. A. S. S. Bachega, and W. L. Miller The Common P450 Oxidoreductase Variant A503V Is Not a Modifier Gene for 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2913 - 2916. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Araujo, B. B. Mendonca, A. S. Barbosa, C. J. Lin, J. A. M. Marcondes, A. E. C. Billerbeck, and T. A. S. S. Bachega Microconversion between CYP21A2 and CYP21A1P Promoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4028 - 4034. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Robins, M. Barbaro, S. Lajic, and A. Wedell Not All Amino Acid Substitutions of the Common Cluster E6 Mutation in CYP21 Cause Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2148 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kharrat, V. Tardy, R. M'Rad, F. Maazoul, L. B. Jemaa, M. Refai, Y. Morel, and H. Chaabouni Molecular Genetic Analysis of Tunisian Patients with a Classic Form of 21-Hydroxylase Deficiency: Identification of Four Novel Mutations and High Prevalence of Q318X Mutation J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 368 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. M. L. Stikkelbroeck, L. H. Hoefsloot, I. J. de Wijs, B. J. Otten, A. R. M. M. Hermus, and E. A. Sistermans CYP21 Gene Mutation Analysis in 198 Patients with 21-Hydroxylase Deficiency in The Netherlands: Six Novel Mutations and a Specific Cluster of Four Mutations J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3852 - 3859. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. C. Billerbeck, B. B. Mendonca, E. M. Pinto, G. Madureira, I. J. P. Arnhold, and T. A. S. S. Bachega Three Novel Mutations in CYP21 Gene in Brazilian Patients with the Classical Form of 21-Hydroxylase Deficiency Due to a Founder Effect J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4314 - 4317. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koyama, T. Toyoura, S. Saisho, K. Shimozawa, and J. Yata Genetic Analysis of Japanese Patients with 21-Hydroxylase Deficiency: Identification of a Patient with a New Mutation of a Homozygous Deletion of Adenine at Codon 246 and Patients without Demonstrable Mutations within the Structural Gene for CYP21 J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2668 - 2673. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. S. S. Bachega, E. M. L. Brenlha, A. E. C. Billerbeck, J. A. M. Marcondes, G. Madureira, I. J. P. Arnhold, and B. B. Mendonca Variable ACTH-Stimulated 17-Hydroxyprogesterone Values in 21-Hydroxylase Deficiency Carriers Are Not Related to the Different CYP21 Gene Mutations J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 786 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Deneux, V. Tardy, A. Dib, E. Mornet, L. Billaud, D. Charron, Y. Morel, and F. Kuttenn Phenotype-Genotype Correlation in 56 Women with Nonclassical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 207 - 213. [Abstract] [Full Text] |
||||
![]() |
A. E. C. Billerbeck, T. A. S. S. Bachega, E. T. Frazzatto, M. Y. Nishi, A. C. Goldberg, M. L. C. Marin, G. Madureira, O. Monte, I. J. P. Arnhold, and B. B. Mendonca A Novel Missense Mutation, GLY424SER, in Brazilian Patients with 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2870 - 2872. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |